SAN ANTONIO, TX. December 18, 2017 – Alternate Health Corp (“Alternate Health” or the “Company”) (CSE:AHG) (OTC:AHGIF), an international, vertically-integrated medical cannabis company, today announced that the Company’s FlorPass patient management system is set to roll out across the state with the beta testing phase currently underway in eight locations, complete with blockchain reporting.

“Alternate Health is working daily with doctors, patients and regulators to offer the most comprehensive software system in the medical cannabis industry,” says Jade Green, V.P. of Sales and Marketing at Alternate Health, who is in Florida this week training multiple physicians on the EMR software. “We are currently onboarding eight medical facilities and their patients to the FlorPass system, and we expect to have a total of 20 clinics and physician offices utilizing the software by the end of our beta test on January 15, 2018.”

Alternate Health officially launched FlorPass at the American Medical Marijuana Physicians Association (‘AMMPA’) Annual Conference in October 2017. The FlorPass EMR received a national endorsement from AMMPA, leading to strong support from doctors across the United States and a current waiting list of over 100 physicians.

After beta-testing is complete in January, Alternate Health expects to roll out the FlorPass software to the remaining doctors on the Florida physicians waiting list. The Company is also actively working on securing beta agreements with Medical Marijuana Treatment Centers (MMTCs), which are the licensed cultivators and dispensary operators in the state of Florida.

“FlorPass continues to gain momentum across the state, and Alternate Health is actively building a blockchain-powered network of key industry players through our technology assets,” says Dr. Michael Murphy, CEO of Alternate Health. “As the Florida market becomes fully monetized, we expect this network to capture consistent and substantial revenues for our software business.”

As the equivalent to Alternate Health’s cornerstone CanaPass technology, FlorPass functions as a cannabis-specific electronic medical record (‘EMR’) system and an e-commerce platform for qualified medical cannabis patients. Alternate’s patient management software will link the physician, patient and licensed cannabis provider in a secure, closed-loop network to regulate, track and monitor medical cannabis purchases and outcomes in multiple legal markets.

Alternate Health’s CanaPass system and blockchain ledger is currently live nationwide in Canada through a partnership with National Access Cannabis (‘NAC’), Canada’s largest chain of medical cannabis clinics. Listed on the TSX Venture Exchange (TSXV:NAC), NAC is currently expanding into recreational markets. Alternate Health plans on launching an adaptation of CanaPass for recreational markets to be deployed in all NAC recreational locations.

About Alternate Health

Alternate Health Corp. (CSE: AHG, OTCQB: AHGIF) Alternate Health has established multiple arms-length operations within the medical cannabis industry, each of which drives consumers, data and strategic opportunities to the company’s other verticals. This sophisticated cross-integration of the company’s enterprises has positioned Alternate Health as one of the only cannabis companies that delivers consistent revenue and intellectual property without growing, manufacturing or distributing the cannabis plant. Through its software solutions, data analytics, and patented delivery systems, Alternate Health’s goal is to be the global authority on scientific and clinical support for cannabis in regulated markets. Alternate Health is well positioned to reinvest internal operating cash flow in its platform over the long term, creating an attractive investment profile for its shareholders.

Alternate Health resides in the cannabis sector along with companies like GW Pharmaceuticals (OTCMKTS:GWPRF), AXIM Biotechnologies Inc. (OTCMKTS:AXIM), Canopy Growth Corporation (TSE:WEED), and Aphria Inc. (TSE:APH). Alternate Health is differentiated from other cannabis companies by its focus on ancillary services for patients, healthcare professionals and regulatory providers rather than selling a commodity. For more information about Alternate Health Corp., visit www.alternatehealth.ca.

Investor Relations Contact:

Nancy Goertzen, CPIR
n.goertzen@alternatehealth.ca
1.604.512.7122

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. Statements included in this announcement, including statements concerning our plans, intentions and expectations, which are not historical in nature are intended to be, and are hereby identified as “forward-looking statements”. Forward-looking statements may be identified by words including “anticipates”, “believes”, “intends”, “estimates”, “expects” and similar expressions. The Company cautions readers that forward-looking statements, including without limitation those relating to the Company’s future operations, business prospects and financing plans, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the forward-looking statements.